Scienture Holdings Reports 216% Revenue Growth for 2025, Despite Stock Decline

Monday, Mar 30, 2026 11:58 am ET1min read
SCNX--

Scienture Holdings reported a 216% increase in net revenue to $431,609 in 2025, driven by the commercial launch of Arbli and progress with REZENOPY. Gross margin expanded to 76.8%, and the company strengthened its commercial footprint through PBM-led and institutional GPO agreements. Scienture expects continued momentum for Arbli and the planned commercial launch of REZENOPY in 2026.

Scienture Holdings Reports 216% Revenue Growth for 2025, Despite Stock Decline

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet